Wednesday March 27, 5:20 pm Eastern Time
Press Release
SOURCE: Hypertension Diagnostics, Inc.
Hypertension Diagnostics Raises $2 Million From Private
Placement
ST. PAUL, Minn., March 27 /PRNewswire-FirstCall/ - Hypertension Diagnostics, Inc. (Nasdaq: HDII - news), announced today that it had raised $2,000,000 through a private placement of 8% Convertible Notes in the principal amount of $2,000,000 and warrants to purchase 250,000 shares of Common Stock of the Company. The Company intends to use the proceeds from the private placement as working capital.
Greg H. Guettler, President of Hypertension Diagnostics, said, "The $2 million in additional funds will aid us in our continuing efforts to bring our CVProfilor® DO-2020 technology to physicians in key U.S. markets."
<abridged>
biz.yahoo.com |
